Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

ClinicalTrials.gov ID: NCT01007123

Public ClinicalTrials.gov record NCT01007123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of Elobixibat in Patients With Chronic Idiopathic Constipation

Study identification

NCT ID
NCT01007123
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Albireo
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

  • A3309 Drug

Drug

Eligibility (public fields only)

Age range
20 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2009
Primary completion
Sep 30, 2010
Completion
Sep 30, 2010
Last update posted
Mar 21, 2017

2009 – 2010

United States locations

U.S. sites
44
U.S. states
25
U.S. cities
43
Facility City State ZIP Site status
Albireo Investigative Site Huntsville Alabama 35801
Albireo Investigative Site Chandler Arizona 85224
Albireo Investigative Site Phoenix Arizona 85020
Albireo Investigative Site Anaheim California 92801
Albireo Investigative Site Encinitas California 92024
Albireo Investigative Site San Diego California 92108
Albireo Investigative Site Colorado Springs Colorado 80904
Albireo Investigative Site Boynton Beach Florida 33426
Albireo Investigative Site Inverness Florida 34452
Albireo Investigative Site Peoria Illinois 61602
Albireo Investigative Site Clive Iowa 50325
Albireo Investigative Site Davenport Iowa 52807
Albireo Investigative Site Mission Kansas 66202
Albireo Investigative Site Overland Park Kansas 66215
Albireo Investigative Site Monroe Louisiana 71201
Albireo Investigative Site Shreveport Louisiana 71103
Albireo Investigative Site Annapolis Maryland 21401
Albireo Investigative Site Baltimore Maryland 21215
Albireo Investigative Site Hollywood Maryland 20636
Albireo Investigative Site Chesterfield Michigan 48047
Albireo Investigative Site Henderson Nevada 89104
Albireo Investigative Site Marlton New Jersey 08053
Albireo Investigative Site Albuquerque New Mexico 87108
Albireo Investigative Site Great Neck New York 11021
Albireo Investigative Site Charlotte North Carolina 28211
Albireo Investigative Site Greensboro North Carolina 27408
Albireo Investigative Site Harrisburg North Carolina 28075
Albireo Investigative Site Statesville North Carolina 28625
Albireo Investigative Site Winston-Salem North Carolina 27103
Albireo Investigative Site Cincinnati Ohio 45224
Albireo Investigative Site Cincinnati Ohio 45242
Albireo Investigative Site Dayton Ohio 45440
Albireo Investigative Site Oklahoma City Oklahoma 73116
Albireo Investigative Site Levittown Pennsylvania 19056
Albireo Investigative Site Anderson South Carolina 29621
Albireo Investigative Site Chattanooga Tennessee 37411
Albireo Investigative Site Kingsport Tennessee 37660
Albireo Investigative Site El Paso Texas 79905
Albireo Investigative Site Longview Texas 75605
Albireo Investigative Site San Antonio Texas 78229
Albireo Investigative Site Ogden Utah 84405
Albireo Investigative Site Salt Lake City Utah 84107
Albireo Investigative Site Lynchburg Virginia 24502
Albireo Investigative Site La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01007123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01007123 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →